Year: 2020

news_6

BeiGene Announces Data on BRUKINSA® (Zanubrutinib) from Phase 2 Trial in Marginal Zone Lymphoma and Phase 3 Trial in Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma at the 62nd ASH Annual Meeting

news_6

Benchmark International Successfully Facilitated the Transaction Between NEWGROUP (Pty.) Ltd. and an Undisclosed Acquirer for the Regal Pet Health Brand

Capetown, South Africa, December 05, 2020 --(PR.com)-- NEWGROUP (Pty.) Ltd. is a private company owning several brands in the complementary...